ASPA Launches Public Awareness Campaign for Counterfeit Drugs

The Authentication Solution Providers' Association (ASPA), a proactive advocate in the fight against counterfeiting, spearheads a robust public awareness campaign, particularly within the pharmaceutical industry. Recognising the urgent need to add...

Emcure Pharmaceuticals Unveils Campaign 'Cure and Beyond' Featuring MS Dhoni

Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies, unveiled its new corporate campaign with the tagline – ‘Cure and Beyond’, featuring cricketer MS Dhoni. In the ever-evolving world of healthcare, Emcure Pharmaceuticals...

IRLAB Bags Swedish Medical Products Agency's Nod To Perform Phase I Study

RLAB Therapeutics, a pharmaceutical firm finding and creating novel therapies for Parkinson's ailments, reported that the Swedish Medical Products Agency has endorsed the commencement of stage I clinical investigation of the medication up-and...

Lupin Bags US FDA Nod for Travoprost Ophthalmic Solution USP

Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application for travoprost ophthalmic solution USP, 0.004% (ionic buffered solution), to market a generic equivalent...

Bespak and H&T Presspart Ink Pact To Advance transition To low GWP Propellants

Bespak, a main contract development and manufacturing organization (CDMO) focused on orally breathed-in and nasal drug-device gadget blend items, and H&T Presspart, a pharmaceutical firm, declared a coordinated effort to speed up the business...

Zydus biopharma Arm Buys Global Proprietary Rights For Progeria Treatment

Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical organization entirely claimed by Ahmedabad-settled Zydus Lifesciences, as of late finished the procurement of worldwide exclusive rights for Zokinvy. Zokinvy is the first and only...

Context Therapeutics Bags US FDA Nod of IND Application

Context Therapeutics Inc, a biopharmaceutical firm creating therapies for solid tumors based in Philadelphia, reported that the US FDA has approved its Investigational New Drug application for CTIM-76, a bispecific antibody that targets Claudin 6...

Cocrystal Pharma Concludes Enrolment in Phase 2a Study of CC-42344

Cocrystal Pharma, Inc. reports that the randomized, double-blind, placebo-controlled phase 2a human challenge clinical study assessing the safety, tolerability, antiviral, and clinical measurements of its novel, oral PB2 inhibitor CC-42344, which...

Abbott Launches Next Generation XIENCE Sierra Stent in India

Abbott, the global healthcare company,announced the launch of XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. XIENCE Sierra is one of the latest generation stents in the XIENCEâ„¢ family, now available to people suffering...

4th Annual Pharma GMP & Quality Management 2024

The 4th Annual Pharma GMP & Quality Management 2024, held at NOVOTEL Mumbai International Airport on April 25th and 26th, emerged as a pivotal event in the pharmaceutical industry landscape, fostering collaboration, innovation, and excellence.

© 2024 India Pharma Outlook. All Rights Reserved.